During the past decade, Etyka Osrodek Badan Klinicznych conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Etyka Osrodek Badan Klinicznych" #1 sponsor was "Bayer" with 2 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "R-Pharm International, LLC" with 2 trials sponsored and "ACELYRIN Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Etyka Osrodek Badan Klinicznych" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Etyka Osrodek Badan Klinicznych" are "Rheumatoid Arthritis" (4 trials), "Arthritis, Psoriatic" (2 trials), "Psoriatic Arthritis" (2 trials), "Atrial Fibrillation" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Etyka Osrodek Badan Klinicznych" in a lesser frequency.

Most popular intervention types in "Etyka Osrodek Badan Klinicznych" are "Drug" (16 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Adalimumab" (2 trials), "GDC-0853" (2 trials), "Guselkumab" (2 trials) and "ABY-035" (1 trials). Other intervention names were less common.

The vast majority of trials in "Etyka Osrodek Badan Klinicznych" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Etyka Osrodek Badan Klinicznych". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Etyka Osrodek Badan Klinicznych, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Etyka Osrodek Badan Klinicznych, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".